For blood testing of hepatitis B patients, blood should first be drawn to check the hepatitis B tri-system to see if the patient is a hepatitis B patient. If the Hepatitis B surface antigen is positive, the patient is considered to have Hepatitis B. At this point, the other items in the Hepatitis B triple system should be looked at further to see if the patient has Hepatitis B Minor Triple Positive or Hepatitis B Major Triple Positive. For patients with minor triple positive, meaning positive for hepatitis B surface antigen, positive for hepatitis B E antibody and positive for hepatitis B core antibody, it is recommended that the patient continue to be observed, and if there is no impairment of liver function, the patient should not be treated. In addition, for patients with triple positive, most of them are positive for Hepatitis B surface antigen, Hepatitis B E antigen, and Hepatitis B core antibody. Positive of these three means that the patient is triple positive. Patients checking hepatitis B DNA suggests that the viral replication is more than 500 copies/ml, considering that the patient has viral replication, and if there is a combination of glutamic oxal transaminase elevation, it is recommended that the patient actively carry out antiviral treatment, which can be injected with interferon, and the patient can be actively treated with antiviral treatment for about half a year to one year, or the patient can continue oral antiviral drugs to carry out antiviral treatment.